Benefits of pulmonary rehabilitation in patients with advanced lymphangioleiomyomatosis (LAM) compared with COPD – a retrospective analysis
Abstract Lymphangioleiomyomatosis (LAM) is a rare and progressive cystic lung disease with limited therapeutic options. We retrospectively analyzed the effects of a comprehensive 4-week inpatient pulmonary rehabilitation (PR) program in 58 patients with advanced LAM (FEV1: 45 ± 34%predicted, 6-min w...
Main Authors: | Rainer Gloeckl, Christoph Nell, Tessa Schneeberger, Inga Jarosch, Martina Boensch, Henrik Watz, Hubert Wirtz, Tobias Welte, Klaus Kenn, Andreas Rembert Koczulla |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-020-01540-3 |
Similar Items
-
Pulmonary lymphangioleiomyomatosis (LAM): A literature overview and case report
by: Cung-Van Cong, MD, PhD, et al.
Published: (2022-05-01) -
Pulmonary lymphangioleiomyomatosis (case report)
by: Shashina M.M., et al.
Published: (2017-12-01) -
Lymphangioleiomyomatosis: what do we know and what are we looking for?
by: O. Torre, et al.
Published: (2011-03-01) -
Improvements in functional and cognitive status following short-term pulmonary rehabilitation in COPD lung transplant recipients: a pilot study
by: Vasileios Andrianopoulos, et al.
Published: (2019-09-01) -
Small airways morphological alterations associated with functional impairment in lymphangioleiomyomatosis
by: Lígia Pelosi Mendonça, et al.
Published: (2024-01-01)